APUS AMEX
Apimeds Pharmaceuticals US, Inc
1W: -55.6%
1M: +22.4%
3M: -62.6%
YTD: -80.7%
1Y: -81.2%
$3.22
-0.88 (-21.46%)
Weekly Expected Move ±68.6%
$-1
$1
$3
$5
$8
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$0M
Revenue
+0.0% YoY
$-58M
Net Income
-2085.0% YoY
$-14M
Free Cash Flow
-312.4% YoY
0.0%
Gross Margin
0.0%
Op. Margin
0.0%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-100.1%
ROA-84.2%
ROIC-12.6%
Valuation
P/E-0.1
P/B0.0
EV/EBITDA-0.5
Leverage
Debt/Equity0.14
Current Ratio0.51
Interest Cov.-12.5x
Quality Scores
Piotroski F2/9
Altman Z-1.79
Beneish M0.00